GlaxoSmithKline plc (GSK)
-NYSE 52.22 
0.11(0.21%) May 17, 4:00PM EDT|After Hours
:
52.22 0.00 (0.00%) May 17, 5:20PM EDT
| Prev Close: | 52.11 |
|---|
| Open: | 51.95 |
|---|
| Bid: | 51.25 x 100 |
|---|
| Ask: | 52.94 x 200 |
|---|
| 1y Target Est: | 48.56 |
|---|
| Beta: | 0.57 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 51.81 - 52.29 |
|---|
| 52wk Range: | 41.68 - 52.65 |
|---|
| Volume: | 1,937,847 |
|---|
| Avg Vol (3m): | 2,768,000 |
|---|
| Market Cap: | 126.48B |
|---|
| P/E (ttm): | 19.09 |
|---|
| EPS (ttm): | 2.74 |
|---|
| Div & Yield: | 2.20 (4.30%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- This Week in Biotechat Motley Fool(Sat 1:45PM EDT)
- 3 Most Important Upcoming FDA Decisions of 2013at Motley Fool(Fri, May 17)
- The Billion Dollar COPD Deal: Who Gains The Most?at Seeking Alpha(Fri, May 17)
- Cheerleaders: Look Beyond Pharma For JobsYCharts(Thu, May 16)
- Time To Show Optimism For Stocksat Seeking Alpha(Thu, May 16)
- Prestige Slides On Revenue Miss But Vows More Buysat Investor's Business Daily(Thu, May 16)
- Theravance Looks to Reward Shareholders by Splitting Into Two Distinct Companiesat Motley Fool(Wed, May 15)
- Amicus Therapeutics: The Good And The Badat Seeking Alpha(Wed, May 15)
- Is Vivus a Buy at These Prices?at Wall St. Cheat Sheet(Wed, May 15)
- Is AstraZeneca Gearing Up for a Shopping Spree?at Motley Fool(Wed, May 15)
- Aveo Screwed Up but Its Kidney Cancer Drug Is Realat TheStreet(Wed, May 15)
- Dirty Medicineat Fortune(Wed, May 15)
- 3 Pharmaceuticals For Attractive Dividendsat Seeking Alpha(Wed, May 15)
- Elan in Royalty Deal with THRXZacks(Tue, May 14)
- Should You Buy Stock in Gilead After the Earnings Miss?at Motley Fool(Tue, May 14)
Key Statistics
| Forward P/E (1 yr): | 12.35 |
|---|
| P/S (ttm): | 2.99 |
|---|
| Ex-Dividend Date: | 08-May-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 3.91 |
|---|
| Quarterly EPS Est
(Mar-13)
: | N/A |
|---|
| Mean Recommendation*: | 2.9 |
|---|
| PEG Ratio (5 yr expected): | 4.17 |
|---|
Business Summary
GlaxoSmithKline plc, together with its subsidiaries, discovers, develops, manufactures, and markets pharmaceutical products, over-the-counter medicines, and health-related consumer products worldwide.
View More